Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Monitoring, Ambulatory | 4 | 2011 | 357 | 0.340 |
Why?
|
Extracellular Fluid | 1 | 2011 | 165 | 0.340 |
Why?
|
Blood Glucose | 7 | 2011 | 6429 | 0.310 |
Why?
|
Benchmarking | 1 | 2011 | 1058 | 0.230 |
Why?
|
Diabetes Mellitus, Type 1 | 4 | 2011 | 3440 | 0.220 |
Why?
|
Hepatitis C, Chronic | 4 | 2009 | 1031 | 0.180 |
Why?
|
Interview, Psychological | 1 | 2004 | 812 | 0.180 |
Why?
|
Medical Records | 1 | 2006 | 1413 | 0.170 |
Why?
|
Hospitals | 2 | 2011 | 3906 | 0.170 |
Why?
|
Guideline Adherence | 2 | 2008 | 2239 | 0.160 |
Why?
|
Glucose | 1 | 2011 | 4355 | 0.160 |
Why?
|
Hepacivirus | 4 | 2009 | 1342 | 0.160 |
Why?
|
Colorectal Neoplasms | 2 | 2011 | 6978 | 0.150 |
Why?
|
Antiviral Agents | 5 | 2009 | 3063 | 0.140 |
Why?
|
World Health Organization | 1 | 2004 | 1328 | 0.140 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2006 | 3550 | 0.140 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 1994 | 0.140 |
Why?
|
Models, Statistical | 1 | 2011 | 5103 | 0.130 |
Why?
|
Antineoplastic Agents | 5 | 2011 | 13708 | 0.130 |
Why?
|
Pancreatectomy | 2 | 2010 | 824 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2011 | 12242 | 0.120 |
Why?
|
California | 2 | 2011 | 1444 | 0.120 |
Why?
|
Coronary Stenosis | 2 | 2011 | 803 | 0.110 |
Why?
|
Registries | 2 | 2011 | 8373 | 0.110 |
Why?
|
Mental Disorders | 2 | 2004 | 6879 | 0.110 |
Why?
|
Aorta, Abdominal | 1 | 2006 | 627 | 0.110 |
Why?
|
Fatty Liver | 2 | 2012 | 807 | 0.110 |
Why?
|
Analgesia, Epidural | 1 | 2006 | 332 | 0.110 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2011 | 2331 | 0.100 |
Why?
|
Bayes Theorem | 3 | 2011 | 2358 | 0.100 |
Why?
|
Sampling Studies | 2 | 2004 | 617 | 0.100 |
Why?
|
Pancreatic Neoplasms | 4 | 2011 | 5442 | 0.100 |
Why?
|
Bronchial Provocation Tests | 1 | 2011 | 216 | 0.100 |
Why?
|
beta Karyopherins | 1 | 2011 | 46 | 0.090 |
Why?
|
Operating Room Information Systems | 1 | 2011 | 15 | 0.090 |
Why?
|
Ribavirin | 2 | 2009 | 395 | 0.090 |
Why?
|
Bronchoconstriction | 1 | 2011 | 141 | 0.090 |
Why?
|
Anesthesia Department, Hospital | 1 | 2011 | 69 | 0.090 |
Why?
|
Stomach Neoplasms | 2 | 2011 | 1484 | 0.090 |
Why?
|
Airway Resistance | 1 | 2011 | 406 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2011 | 20231 | 0.090 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2011 | 117 | 0.090 |
Why?
|
Matched-Pair Analysis | 1 | 2011 | 286 | 0.090 |
Why?
|
Epidemiologic Research Design | 2 | 2004 | 368 | 0.090 |
Why?
|
Hepatitis C | 3 | 2009 | 1594 | 0.090 |
Why?
|
Adult | 33 | 2012 | 223542 | 0.090 |
Why?
|
Amantadine | 1 | 2009 | 59 | 0.080 |
Why?
|
Nitrogen Radioisotopes | 1 | 2009 | 44 | 0.080 |
Why?
|
Anesthesia | 2 | 2011 | 1596 | 0.080 |
Why?
|
Insulin Infusion Systems | 1 | 2011 | 221 | 0.080 |
Why?
|
Liver Cirrhosis | 3 | 2009 | 1950 | 0.080 |
Why?
|
Radiopharmaceuticals | 2 | 2009 | 2731 | 0.080 |
Why?
|
Middle Aged | 32 | 2012 | 223418 | 0.080 |
Why?
|
Liver Neoplasms | 3 | 2011 | 4362 | 0.080 |
Why?
|
Mountaineering | 1 | 2008 | 45 | 0.080 |
Why?
|
alpha-Fetoproteins | 1 | 2009 | 228 | 0.080 |
Why?
|
Interferon-alpha | 2 | 2009 | 909 | 0.080 |
Why?
|
Virus Activation | 1 | 2010 | 322 | 0.080 |
Why?
|
Isoflurane | 1 | 2011 | 384 | 0.080 |
Why?
|
Ammonia | 1 | 2009 | 249 | 0.080 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 178 | 0.080 |
Why?
|
Postprandial Period | 1 | 2010 | 319 | 0.070 |
Why?
|
Eyeglasses | 1 | 2009 | 138 | 0.070 |
Why?
|
Aged | 26 | 2012 | 171520 | 0.070 |
Why?
|
Biliary Tract Neoplasms | 1 | 2009 | 187 | 0.070 |
Why?
|
Surgical Stapling | 1 | 2008 | 100 | 0.070 |
Why?
|
Tubulin | 1 | 2011 | 695 | 0.070 |
Why?
|
Medical Records Systems, Computerized | 2 | 2011 | 1193 | 0.070 |
Why?
|
STAT1 Transcription Factor | 1 | 2009 | 343 | 0.070 |
Why?
|
Pancreatic Fistula | 1 | 2008 | 149 | 0.070 |
Why?
|
Gallbladder Neoplasms | 1 | 2009 | 191 | 0.070 |
Why?
|
Male | 36 | 2012 | 364781 | 0.070 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 695 | 0.070 |
Why?
|
Polyethylene Glycols | 2 | 2009 | 1195 | 0.070 |
Why?
|
GB virus C | 1 | 2006 | 9 | 0.070 |
Why?
|
Hepatitis B virus | 1 | 2010 | 530 | 0.070 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2008 | 197 | 0.070 |
Why?
|
Myopia | 1 | 2009 | 252 | 0.070 |
Why?
|
Anesthetics, Inhalation | 1 | 2011 | 575 | 0.070 |
Why?
|
Clinical Laboratory Techniques | 1 | 2012 | 749 | 0.070 |
Why?
|
Bronchi | 1 | 2010 | 847 | 0.070 |
Why?
|
Female | 35 | 2012 | 396943 | 0.070 |
Why?
|
Foreign Bodies | 1 | 2010 | 403 | 0.070 |
Why?
|
Hepatitis B, Chronic | 1 | 2010 | 413 | 0.060 |
Why?
|
Hepatitis, Viral, Human | 1 | 2006 | 141 | 0.060 |
Why?
|
Neurologic Examination | 1 | 2009 | 916 | 0.060 |
Why?
|
Pain, Postoperative | 1 | 2006 | 1763 | 0.060 |
Why?
|
Adolescent | 11 | 2011 | 89168 | 0.060 |
Why?
|
Eye | 1 | 2009 | 715 | 0.060 |
Why?
|
Cholesterol, LDL | 2 | 2012 | 2396 | 0.060 |
Why?
|
Insulin | 2 | 2011 | 6606 | 0.060 |
Why?
|
Cataract Extraction | 1 | 2009 | 465 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2012 | 6320 | 0.060 |
Why?
|
Vasodilator Agents | 1 | 2009 | 991 | 0.060 |
Why?
|
Trachea | 1 | 2010 | 1095 | 0.060 |
Why?
|
Adenosine | 1 | 2009 | 816 | 0.060 |
Why?
|
Sirolimus | 1 | 2011 | 1542 | 0.060 |
Why?
|
Survival Analysis | 3 | 2011 | 10125 | 0.060 |
Why?
|
Aged, 80 and over | 12 | 2011 | 59680 | 0.060 |
Why?
|
Humans | 41 | 2012 | 768451 | 0.050 |
Why?
|
Kinetics | 1 | 2011 | 6348 | 0.050 |
Why?
|
Mathematical Computing | 1 | 2003 | 142 | 0.050 |
Why?
|
Antibodies, Monoclonal | 2 | 2011 | 9263 | 0.050 |
Why?
|
Indoles | 1 | 2011 | 1834 | 0.050 |
Why?
|
Cause of Death | 2 | 2008 | 3727 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1795 | 0.050 |
Why?
|
Coronary Circulation | 1 | 2009 | 1617 | 0.050 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2010 | 1376 | 0.050 |
Why?
|
Exercise Test | 1 | 2011 | 2186 | 0.050 |
Why?
|
Positron-Emission Tomography | 2 | 2009 | 6657 | 0.050 |
Why?
|
Models, Theoretical | 2 | 2012 | 3590 | 0.050 |
Why?
|
Pitch Perception | 1 | 2003 | 101 | 0.050 |
Why?
|
Nerve Block | 1 | 2009 | 711 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2011 | 2067 | 0.050 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 1518 | 0.050 |
Why?
|
Logistic Models | 3 | 2011 | 13324 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2705 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2009 | 2048 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2012 | 2238 | 0.050 |
Why?
|
Quality Indicators, Health Care | 1 | 2011 | 1813 | 0.040 |
Why?
|
Anesthesiology | 1 | 2011 | 1137 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2011 | 2964 | 0.040 |
Why?
|
Quality Assurance, Health Care | 1 | 2011 | 2179 | 0.040 |
Why?
|
Low Back Pain | 1 | 2009 | 989 | 0.040 |
Why?
|
Cross-Cultural Comparison | 1 | 2004 | 639 | 0.040 |
Why?
|
Esophageal Neoplasms | 1 | 2011 | 1676 | 0.040 |
Why?
|
Analgesics, Opioid | 1 | 2006 | 3837 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2009 | 2062 | 0.040 |
Why?
|
Chi-Square Distribution | 3 | 2011 | 3438 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2011 | 2585 | 0.040 |
Why?
|
Young Adult | 9 | 2011 | 60045 | 0.040 |
Why?
|
Comorbidity | 2 | 2004 | 10601 | 0.040 |
Why?
|
Pain Measurement | 1 | 2009 | 3577 | 0.040 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2009 | 1755 | 0.040 |
Why?
|
Lipids | 1 | 2009 | 3346 | 0.040 |
Why?
|
Lymph Nodes | 1 | 2009 | 3472 | 0.040 |
Why?
|
Ventricular Function, Left | 1 | 2011 | 3941 | 0.040 |
Why?
|
Cognition Disorders | 1 | 2011 | 3985 | 0.040 |
Why?
|
Electrocardiography | 1 | 2011 | 6410 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2004 | 2362 | 0.040 |
Why?
|
Retrospective Studies | 13 | 2011 | 81834 | 0.040 |
Why?
|
Arousal | 1 | 2003 | 1182 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2004 | 2731 | 0.030 |
Why?
|
Liver | 2 | 2009 | 7575 | 0.030 |
Why?
|
Data Collection | 1 | 2006 | 3329 | 0.030 |
Why?
|
RNA, Viral | 3 | 2009 | 2865 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2010 | 3197 | 0.030 |
Why?
|
Critical Care | 1 | 2008 | 2717 | 0.030 |
Why?
|
Treatment Outcome | 9 | 2011 | 65409 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2009 | 26351 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2011 | 15965 | 0.030 |
Why?
|
Boston | 3 | 2011 | 9361 | 0.030 |
Why?
|
Cognition | 1 | 2011 | 7066 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2010 | 4298 | 0.030 |
Why?
|
Health Surveys | 1 | 2004 | 4056 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6400 | 0.030 |
Why?
|
Linear Models | 1 | 2003 | 5880 | 0.030 |
Why?
|
Anesthetics, Combined | 1 | 2012 | 43 | 0.030 |
Why?
|
Asthma | 1 | 2011 | 6274 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 5887 | 0.020 |
Why?
|
Spectrophotometry | 1 | 2012 | 292 | 0.020 |
Why?
|
Reference Values | 2 | 2010 | 4941 | 0.020 |
Why?
|
Time Factors | 5 | 2011 | 40271 | 0.020 |
Why?
|
HIV Infections | 2 | 2009 | 17564 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2006 | 11249 | 0.020 |
Why?
|
Hepatitis Antibodies | 1 | 2010 | 67 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2006 | 4340 | 0.020 |
Why?
|
Lung Volume Measurements | 1 | 2011 | 383 | 0.020 |
Why?
|
Viral Load | 2 | 2009 | 3399 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2009 | 6527 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2003 | 4077 | 0.020 |
Why?
|
Coloring Agents | 1 | 2012 | 564 | 0.020 |
Why?
|
Hepatitis C Antibodies | 1 | 2009 | 151 | 0.020 |
Why?
|
Genotype | 3 | 2009 | 13047 | 0.020 |
Why?
|
Regression Analysis | 2 | 2010 | 6353 | 0.020 |
Why?
|
Neuralgia, Postherpetic | 1 | 2009 | 41 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2009 | 6856 | 0.020 |
Why?
|
Spinal Nerve Roots | 1 | 2009 | 122 | 0.020 |
Why?
|
Hypertension | 1 | 2009 | 8611 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11843 | 0.020 |
Why?
|
Anesthesia, Spinal | 1 | 2011 | 282 | 0.020 |
Why?
|
Serologic Tests | 1 | 2010 | 383 | 0.020 |
Why?
|
Intubation, Intratracheal | 1 | 2006 | 1359 | 0.020 |
Why?
|
Organoplatinum Compounds | 1 | 2009 | 408 | 0.020 |
Why?
|
Altitude Sickness | 1 | 2008 | 92 | 0.020 |
Why?
|
Contact Lenses | 1 | 2009 | 138 | 0.020 |
Why?
|
APACHE | 1 | 2008 | 268 | 0.020 |
Why?
|
Nerve Compression Syndromes | 1 | 2009 | 160 | 0.020 |
Why?
|
Physical Stimulation | 1 | 2009 | 517 | 0.020 |
Why?
|
Weather | 1 | 2008 | 232 | 0.020 |
Why?
|
Biopsy | 2 | 2009 | 6816 | 0.020 |
Why?
|
Mexico | 1 | 2009 | 766 | 0.020 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 495 | 0.020 |
Why?
|
Decision Trees | 1 | 2009 | 510 | 0.020 |
Why?
|
Hypothermia | 1 | 2008 | 188 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2003 | 5827 | 0.020 |
Why?
|
Death, Sudden | 1 | 2008 | 301 | 0.020 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2010 | 475 | 0.020 |
Why?
|
Mutation | 1 | 2011 | 30243 | 0.020 |
Why?
|
Demography | 1 | 2011 | 1643 | 0.020 |
Why?
|
Hospitals, General | 1 | 2011 | 807 | 0.020 |
Why?
|
Family Health | 1 | 2011 | 1256 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 9066 | 0.020 |
Why?
|
Prospective Studies | 4 | 2012 | 54914 | 0.020 |
Why?
|
Workflow | 1 | 2011 | 861 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 1142 | 0.020 |
Why?
|
Software | 2 | 2011 | 4463 | 0.020 |
Why?
|
China | 1 | 2011 | 2398 | 0.020 |
Why?
|
Diabetic Neuropathies | 1 | 2009 | 411 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 13026 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2009 | 888 | 0.020 |
Why?
|
Prognosis | 3 | 2010 | 30028 | 0.010 |
Why?
|
Interdisciplinary Communication | 1 | 2010 | 937 | 0.010 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2011 | 672 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2009 | 12561 | 0.010 |
Why?
|
Massachusetts | 2 | 2009 | 8908 | 0.010 |
Why?
|
Bronchoscopy | 1 | 2010 | 913 | 0.010 |
Why?
|
Risk Assessment | 3 | 2011 | 24311 | 0.010 |
Why?
|
Abdominal Pain | 1 | 2010 | 1070 | 0.010 |
Why?
|
Organ Size | 1 | 2009 | 2268 | 0.010 |
Why?
|
Equipment Design | 1 | 2012 | 3530 | 0.010 |
Why?
|
Child | 5 | 2010 | 80863 | 0.010 |
Why?
|
Neoplasm, Residual | 1 | 2009 | 1014 | 0.010 |
Why?
|
Checklist | 1 | 2011 | 843 | 0.010 |
Why?
|
Fasting | 1 | 2010 | 1608 | 0.010 |
Why?
|
Pedigree | 1 | 2011 | 4545 | 0.010 |
Why?
|
Age Distribution | 1 | 2009 | 2881 | 0.010 |
Why?
|
Suture Techniques | 1 | 2008 | 776 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2863 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2008 | 2228 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2011 | 15460 | 0.010 |
Why?
|
Administration, Oral | 1 | 2011 | 4041 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2011 | 6242 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2009 | 8051 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2656 | 0.010 |
Why?
|
Interferons | 1 | 2006 | 714 | 0.010 |
Why?
|
Risk Factors | 4 | 2011 | 74915 | 0.010 |
Why?
|
Program Evaluation | 1 | 2011 | 2508 | 0.010 |
Why?
|
Event-Related Potentials, P300 | 1 | 2003 | 149 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2009 | 2930 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 3637 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2010 | 1389 | 0.010 |
Why?
|
ROC Curve | 1 | 2009 | 3624 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2009 | 1898 | 0.010 |
Why?
|
Accidental Falls | 1 | 2008 | 1081 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2011 | 4931 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2009 | 22293 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 6995 | 0.010 |
Why?
|
Cholesterol | 1 | 2009 | 2910 | 0.010 |
Why?
|
Incidence | 2 | 2009 | 21552 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2009 | 36840 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2006 | 2596 | 0.010 |
Why?
|
United States | 2 | 2008 | 73121 | 0.010 |
Why?
|
Sarcoma | 1 | 2010 | 1806 | 0.010 |
Why?
|
Point-of-Care Systems | 1 | 2008 | 1228 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4586 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6537 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2010 | 2544 | 0.010 |
Why?
|
Random Allocation | 1 | 2003 | 2399 | 0.010 |
Why?
|
Odds Ratio | 1 | 2011 | 9687 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2011 | 7134 | 0.010 |
Why?
|
Pilot Projects | 1 | 2011 | 8730 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2008 | 2010 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2009 | 4526 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 8559 | 0.010 |
Why?
|
Stroke Volume | 1 | 2011 | 5620 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2009 | 12096 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2009 | 12450 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2003 | 1894 | 0.010 |
Why?
|
Survival Rate | 1 | 2009 | 12875 | 0.010 |
Why?
|
Mass Screening | 1 | 2010 | 5455 | 0.010 |
Why?
|
Artifacts | 1 | 2003 | 1927 | 0.010 |
Why?
|
Disease Progression | 1 | 2011 | 13655 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2008 | 5371 | 0.010 |
Why?
|
Chronic Disease | 1 | 2009 | 9382 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2006 | 15880 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14728 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2010 | 4906 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7451 | 0.010 |
Why?
|
Melanoma | 1 | 2010 | 5740 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2009 | 6551 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 18048 | 0.010 |
Why?
|
Prevalence | 1 | 2006 | 15880 | 0.010 |
Why?
|
Signal Transduction | 1 | 2011 | 23638 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2009 | 39430 | 0.000 |
Why?
|
Brain Mapping | 1 | 2003 | 6740 | 0.000 |
Why?
|
Child, Preschool | 1 | 2010 | 42623 | 0.000 |
Why?
|
Cohort Studies | 1 | 2009 | 41797 | 0.000 |
Why?
|